[{"age": null, "album": "", "artist": null, "bookmarked": false, "comments": [], "date_published": "2024-06-11T21:10:49+00:00", "description": "Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)\n\nhttps://news.modernatx.com/news/news-details/2024/Moderna-Receives-U.S.-FDA-Approval-for-RSV-Vaccine-mRESVIAR/default.aspx\n\nMay 31, 2024\n\nModerna, today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), \n\nan mRNA respiratory syncytial virus (RSV) vaccine, \n\nto protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection. \n\nThe approval was granted under a breakthrough therapy designation and marks the second approved mRNA product from Moderna.\n\nSt\u00e9phane Bancel, Chief Executive Officer of Moderna.\n\nThe FDA approval of our second product, mRESVIA, builds on the strength and versatility of our mRNA platform\n\nModerna expects to have mRESVIA available for eligible populations in the U.S. by the 2024/2025 respiratory virus season.\n\nModerna has filed for mRNA-1345 approval with regulators in multiple markets around the world.\n\nhttps://www.clinicaltr", "language": null, "link": "https://www.youtube.com/watch?v=tFzTTuuzfH0", "manual_status_code": 0, "page_rating": 32, "page_rating_contents": 100, "page_rating_visits": 0, "page_rating_votes": 0, "permanent": false, "source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "source_obj__id": 96, "status_code": 0, "tags": [], "thumbnail": "https://i1.ytimg.com/vi/tFzTTuuzfH0/hqdefault.jpg", "title": "Future developments", "user": null, "vote": 0}]